Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09UKH
|
||||
| Former ID |
DCL001257
|
||||
| Drug Name |
XL550
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 1 | [550638] | ||
| Company |
Exelixis; Daiichi-Sankyo
|
||||
| Target and Pathway | |||||
| Target(s) | Mineralocorticoid receptor | Target Info | Antagonist | [550638] | |
| KEGG Pathway | Aldosterone-regulated sodium reabsorption | ||||
| PathWhiz Pathway | Kidney Function | ||||
| WikiPathways | ACE Inhibitor Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.